7
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Viruses can silently prime for and trigger central nervous system autoimmune disease

Pages 220-227 | Published online: 10 Jul 2009

References

  • Alter M, Okihiro M, Rowley W, Morris T (1971). Multi-ple sclerosis among Orientals and Caucasians in Hawaii. Neurology 21: 122–130.
  • Alter M, Zhang ZX, Davanipour Z, Sobel E, Zibulewski J, Schwartz G, Friday G (1986). Multiple sclerosis and childhood infections. Neurology 36: 1386–1389.
  • Amor S, Groome N, Linington C, Morris MM, Dorn-mair K, Gardinier MV, Matthieu J-M, Baker D (1994). Identification of epitopes of myelin oligodendrocyte gly-copr otein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 153: 4349–4356.
  • Andersen O, Lygner P-E, Bergstrom T, Andersson M, Vahlne A (1993). Viral infections trigger multiple scle rosis relapses: a prospective seroepidemiologic al study. J Neurol 240: 417–422.
  • Anderson DW, Ellenberg JH, Leventhal CM, Reingold SC, Rodriguez M, Silberberg DH (1992). Revised estimate of the prevalence of multiple sclerosis in the United States. Ann Neurol 31: 333–336.
  • Baker D, Rosenwasser OA, O'Neill JK, Turk JL (1995). Ge-netic analysis of experimental allergic encephalomyeli-tis in mice. Jimmunol 155: 4046–4051.
  • Barnett LA, Whitton JL, Wada Y, Fujinami RS (1993). Enhancement of autoimmune disease using recombi-nant vaccinia virus encoding myelin proteolipid pro-tein [published erratum appears in J Neuroimmunol 1993;48:120]. J Neuroimmunol 44: 15–25.
  • Berger T, Weerth S, Kojima K, Linington C, Wekerle H, Lassmann H (1997). Experimental autoimmune en-cephalomyelitis: the antigen specificity of T lympho-cytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest 76: 355–364.
  • Butterfield RJ, Blankenhorn EP, Roper RJ, Zachary JF, Doerge RW, Sudweeks J, Rose J, Teuscher C (1999). Genetic analysis of disease subtypes and sexual dimorphisms in mouse experimental allergic encephalomyelitis (EAE): Relapsing/remitting and monophasic remitting/nonrelapsing EAE are im-munogenetically distinct. I Immunol 162: 3096–3102.
  • Butterfield RJ, Sudweeks JD, Blankenhorn EP, Korngold R, Marini JC, Todd JA, Roper RJ, Teuscher C (1998). New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. J Immunol 161: 1860–1867.
  • Charles PC, Weber KS, Cipriani B, Brosnan CF (1999). Cytokine, chemokine and chemokine receptor mRNA expression in different strains of normal mice: implica-tions for establishment of a Th1/Th2 bias. I Neuroim-munol 100: 64–73.
  • Dean G, Kurtzke JF (1971). On the risk of multiple sclerosis according to age at immigration to South Africa. Br Med J3: 725–729.
  • Edwards S, Zvartau M, Clarke H, Irving W, Blumhardt LD (1998). Clinical relapses and disease activity on mag-netic resonance imaging associated with viral upper res-piratory tract infections in multiple sclerosis. I Neurol Neurosurg Psychiatry 64: 736–741.
  • Encinas JA, Lees MB, Sobel RA, Symonowicz C, Greer JM, Shovlin CL, Weiner HL, Seidman CE, Seidman JG, Kuchroo VK (1996). Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10.S mice. I Immunol 157: 2186–2192.
  • Freund J, Stern ER, Pisani TM (1947). Isoallergic en-cephalomyelitis and radiculitis in guinea pigs after one injection of brain and mycobacteria in water-in-oil emul-sion. J Immunol 57: 179–193.
  • Fujinami RS, Oldstone MBA (1985). Amino acid homology between the encephalitogenic site of myelin basic pro-tein and virus: mechanism for autoimmunity. Science 230: 1043–1045.
  • Goverman J (1999). Tolerance and autoimmunity in TCR transgenic mice specific for myelin basic protein. Im-munol Rev 169: 147–159.
  • Illés Z, Kondo T, Yokoyama K, Ohashi T, Tabira T, Yamamura T (1999). Identification of autoimmune T cells among in vivo expanded CD25 T cells in mul-tiple sclerosis. I Immunol 162: 1811–1817.
  • James WH (1988). Further evidence in support of the hy-pothesis that one cause of multiple sclerosis is child-hood infection. Neuroepidemiology 7: 130–133.
  • Kabat EA, Wolf A, Bezer AE (1946). Rapid production of acute disseminated encephalomyelitis in Rhesus mon-keys by infection of brain tissue with adjuvants. Science 104: 362–363.
  • Kabat EA, Wolf A, Bezer AE (1947). The rapid production of acute disseminated encephalomyelitis in Rhesus mon-keys by infection of heterologous and homologous brain tissue with adjuvants. J Exp Med 85: 117–128.
  • Kalman B, Lublin FD (1999). The genetics of multiple scle-rosis. A review. Biomed Pharmacother 53: 358–370.
  • Kerlero de Rosbo N, Bernard CCA, Simmons RD, Carnegie PR (1985). Concomitant detection of changes in myelin basic protein and permeability of blood-spinal cord barrier in acute experimental autoimmune en-cephalomyelitis by electroimmunoblotting. I Neuroim-munol 9: 349–361.
  • Kopeloff LM, Kopeloff N (1947). Neurologic manifesta-tions in laboratory animals produced by organ (adju-vant) emulsions. J Immunol 57: 229–237.
  • Kurtzke JF (1993). Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 6: 382–427.
  • Levine S, Simon J, Wenk EJ (1966). Edema of the spinal cord in experimental allergic encephalomyelitis. Proc Soc Exp Biol Med 123: 539–541.
  • Livingstone KD, Sudweeks JD, Blankenhorn EP, Hickey WF, Teuscher C (1995). Susceptibility to actively-induced murine experimental allergic encephalomyelitis is not linked to genes of the T cell receptor or CD3 complexes. A utoimmunity 21: 195–201.
  • Martin R (1997). Genetics of multiple sclerosis-how could disease-associated HLA- types contribute to pathogene-sis? J Neural Transm Suppl 49: 177–194.
  • Metz LM, McGuinness SD, Harris C (1998). Urinary tract in-fections may trigger relapse in multiple sclerosis. Axone 19: 67–70.
  • Morgan IM (1946). Allergic encephalomyelitis in monkeys in response to injection of normal monkey cord. I Bac-teriology 51: 614.
  • Morgan IM (1947). Allergic encephalomyelitis in monkeys in response to injection of normal monkey nervous tis-sue. J Exp Med 85: 131–140.
  • Morrison LA (1947). Disseminated encephalomyelitis ex-perimentally produced by the use of homologous anti-gen. Arch Neurol & Psychiat 58: 391–416.
  • Morrison W, Nelson J (1994). Environmental triggers in multiple sclerosis. Fact or fallacy? Axone 16: 23–26.
  • Panitch HS (1994). Influence of infection on exacerbations of multiple sclerosis. Ann Neurol 36 Suppl: S25–S28.
  • Rapp NS, Gilroy J, Lerner AM (1995). Role of bacterial in-fection in exacerbation of multiple sclerosis. Am J Phys Med Rehabil 74: 415–418.
  • Rodriguez F, An LL, Harkins S, Zhang J, Yokoyama M, Widera G, Fuller JT, Kincaid C, Campbell IL, Whitton JL (1998). DNA immunization with minigenes: low fre-quency of memory cytotoxic T lymphocytes and ineffi-cient antiviral protection are rectified by ubiquitination. I Virol 72: 5174–5181.
  • Sibley WA, Bamford CR, Clark K (1985). Clinical viral in-fections and multiple sclerosis. Lancet 1: 1313–1315.
  • Simmons RD, Bernard CCA, Singer G, Carnegie PR (1982). Experimental autoimmune encephalomyelitis. An anatomically-based explanation of clinical progres-sion in rodents. J Neuroimmunol 3: 307–318.
  • Smith ME, Eller NL, McFarland HF, Racke MK, Raine CS (1999). Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implica-tions for multiple sclerosis. Am I Pathol 155: 1147–1161.
  • Sobel RA, van der Veen RC, Lees MB (1986). The im-munopathology of chronic experimental allergic en-cephalomyelitis induced in rabbits with bovine prote-olipid protein. J Immunol 136: 157–163.
  • Teuscher C, Butterfield RJ, Ma RZ, Zachary JF, Doerge RW, Blankenhorn EP (1999). Sequence polymorphisms in the chemokines Scya1 (TCA-3), Scya2 (monocyte chemoattractant protein (MCP)-1), and Scya12 (MCP-5) are candidates for eae7, a locus controlling susceptibil-ity to monophasic remitting/nonrelapsing experimental allergic encephalomyelitis. I Immunol 163: 2262–2266.
  • Trotter JL, Pelfrey CM, Trotter AL, Selvidge JA, Gushleff KC, Mohanakumar T, McFarland HF (1998). T cell recognition of myelin proteolipid protein and myelin proteolipid protein peptides in the peripheral blood of multiple sclerosis and control subjects. Neuroimmunol 84: 172–178.
  • Tsunoda I, Fujinami RS (1996). Two models for multi-ple sclerosis: Experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. I Neu-ropathol Exp Neurol 55: 673–686.
  • Tsunoda I, Kuang L-Q Tolley ND, Whitton JL, Fujinami RS (1998). Enhancement of experimental allergic en-cephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA. I Neu-ropathol Exp Neurol 57: 758–767.
  • Tsunoda I, Kuang L-Q Theil DJ, Fujinami RS (2000). An-tibody association with a novel model for primary pro-gressive multiple sclerosis: Induction of relapsing- remitting and progressive forms of EAE in H2s mouse strains. Brain Pathol 10: 402–418.
  • Tsunoda I, Tolley ND, Theil DJ, Whitton JL, Kobayashi H, Fujinami RS (1999). Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA. Brain Pathol 9: 481–493.
  • Weerth S, Berger T, Lassmann H, Linington C (1999). En-cephalitogenic and neuritogenic T cell responses to the myelin-associated glycoprotein (MAG) in the Lewis rat. J Neuroimmunol 95: 157–164.
  • Weinshenker BG, Santrach P, Bissonet AS, McDonnell SK, Schaid D, Moore SB, Rodriguez M (1998). Major histo-compatibility complex class II alleles and the course and outcome of MS: a population-based study. Neurology 51: 742–747.
  • Whitton JL, Oldstone MBA (1996). Immune response to viruses. In: Fields Virology. Fields BN, Knipe DM, Howley PM (eds). Third edition Lippincott-Raven: Philadelphia, pp 345–374.
  • Yoshimura T, Kunishita T, Sakai K, Endoh M, Namikawa T, Tabira T (1985). Chronic experimental allergic encephalomyelitis in guinea pigs induced by prote-olipid protein. J Neurol Sci 69: 47–58.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.